Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06159634 · ClinicalTrials.gov registry record · NA
Traction vs. No Traction in Colonic ESD
A NA study of Gastrointestinal Neoplasm, sponsored by Baylor College of Medicine.
- Recruiting
- Registry status
- NA
- Development phase
- 150
- Enrollment target
- 2
- Study locations
NCT06159634: Recruiting NA study of Gastrointestinal Neoplasm, sponsored by Baylor College of Medicine.
NCT06159634 is a NA study of Gastrointestinal Neoplasm that is actively recruiting participants, run by Baylor College of Medicine. The registered enrollment target is 150 participants, above the 79-participant average among 4 other Gastrointestinal Neoplasm trials with a reported enrollment target (90% higher). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06159634, a NA study of Gastrointestinal Neoplasm, is actively recruiting participants, sponsored by Baylor College of Medicine.
- RECRUITING
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
- 2
- Study locations
Study Summary
The goal of this prospective, randomized, controlled trial conducted at Baylor St. Luke's Medical Center is to compare the effectiveness and clinical outcomes of using a traction device in colonic endoscopic submucosal dissection (ESD) to those of using conventional ESD. The investigators of this study hypothesize that use of the traction device will help expedite colonic endoscopic submucosal dissections.
Primary Outcome
Length of time to perform endoscopic submucosal dissection by the operator as measured by calculating area of lesion divided by time (cm\^2/hours).
Conditions Studied
Interventions
- PROCEDURE Endoscopic Submucosal Dissection
- DEVICE Traction Device
Study Locations (2)
Texas
- Baylor College of Medicine - Houston
- Baylor St. Lukes Medical Center (BSLMC) - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2023-12-05 |
| Est. Completion | 2026-06-30 |
| Phase | NA |
What NCT06159634 shows while recruiting
NCT06159634 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, above the 79-participant average among 4 other Gastrointestinal Neoplasm trials with a reported enrollment target (90% higher).
The record links to 1 condition, with Gastrointestinal Neoplasm appearing as the primary indexed condition, and to 2 interventions - of which Endoscopic Submucosal Dissection is the first listed.
NCT06159634 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT06159634 about?
NCT06159634 is a clinical study titled "Traction vs. No Traction in Colonic ESD". The goal of this prospective, randomized, controlled trial conducted at Baylor St. Luke's Medical Center is to compare the effectiveness and clinical outcomes of using a traction device in colonic endoscopic submucosal dissection (ESD) to those of using conventional ESD. The investigators of this s...
What is the current status of trial NCT06159634?
This trial is currently recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2023-12-05. Estimated completion is 2026-06-30.
What conditions does trial NCT06159634 study?
This clinical trial studies the following conditions: Gastrointestinal Neoplasm.
What interventions are being tested in trial NCT06159634?
The interventions under investigation include: Endoscopic Submucosal Dissection (PROCEDURE), Traction Device (DEVICE).
Who is sponsoring clinical trial NCT06159634?
This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06159634 being conducted?
This trial has 2 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gastrointestinal Neoplasm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Novel Rigidizing Overtube in Colonic Endoscopic Submucosal Dissection
RECRUITING · NA
-
AI for Onsite Cytology Evaluation in Endoscopic Ultrasound
RECRUITING
-
A Study Comparing Oral Picoplatin With Intravenous Picoplatin in Subjects With Solid Tumors
COMPLETED · Phase 1
-
Debulking and Chemotherapy With or Without Intraperitoneal Chemotherapy to Treat Peritoneal Carcinomatosis
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI